Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO4929097 in Advanced NSCLC After Front-Line Chemotherapy
NCT01193868Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Sep 2010
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RO4929097 in non-small cell lung cancer (NSCLC), sponsored by National Cancer Institute. Started Sep 2010; status: terminated.
02
Drugs
RO4929097
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01193868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01193868.